Related Experiment Video

Updated: May 29, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

[Current status and development of miRNA and siRNA research on gastric cancer]

Miao He1, Zi-Wei Wang

  • 1Department of General Surgery, Chongqing Medical University, Chongqing 400016, China. hemiao7777777@163.com

Yi Chuan = Hereditas
|September 29, 2011
PubMed

Insights

RNA interference (RNAi) regulates gene expression and is linked to cancer. MicroRNA (miRNA) and small interference RNA (siRNA) are key players with diagnostic and therapeutic potential in gastric cancer and other tumors.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Genomics

Context:

  • RNA interference (RNAi) is a crucial epigenetic mechanism regulating gene expression post-DNA replication.
  • RNAi pathways, involving microRNA (miRNA) and small interference RNA (siRNA), are implicated in the development of malignant tumors.
  • Gastric cancer research increasingly focuses on understanding RNAi's role.

Purpose:

  • To review the fundamental principles of miRNA and siRNA.
  • To present recent advancements in RNAi research specifically concerning gastric cancer.
  • To explore the diagnostic and therapeutic applications of RNAi in oncology.

Summary:

  • This review details the basic theories behind microRNA (miRNA) and small interference RNA (siRNA).
  • It highlights current progress in applying RNA interference (RNAi) techniques to gastric cancer research.
  • The review covers the function, mechanisms, and potential clinical uses of RNAi in various cancers.

Impact:

  • RNAi analysis provides powerful tools for elucidating gene function and mechanisms.
  • RNAi technologies show significant promise for the diagnosis and treatment of gastric cancer.
  • The findings suggest broad applicability of RNAi in the broader field of oncology.

More Related Videos

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...